Serum Dkk-1 Is Associated with Pain Intensity, Flare-Ups, and Bone Mineral Density in Non-Obese Patients with Knee Osteoarthritis: A Single-Center, Cross-Sectional Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052216 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Timea-Csilla Nagy-Finna und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medicine and Pharmacy, I.O.S.U.D., George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 54…. Hauptthemen laut MEDLINE: Intercellular Signaling Peptides and Proteins, Osteoarthritis, Knee, Bone Density, Pain. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis is the most common musculoskeletal disorder. It primarily affects people in their mid-40s and older. As the disease progresses, degenerative changes occur in the synovial membrane, subchondral bone, and cartilage. Ultimately, the entire joint and its surrounding tissues become structurally and functionally impaired. Several sets of biochemical markers have been proposed to enable timely diagnosis and anticipate disease progression. However, only a few of these markers are routinely used to evaluate disease activity in subgroups. We conducted a cross-sectional, single-center cohort study of 72 patients with knee osteoarthritis. Diagnoses were established based on clinical data and radiological findings. We examined two Wnt/β-catenin signaling inhibitors, serum DKK-1 and sclerostin, and two bone/cartilage metabolic regulatory factors, RANKL and OPG, correlating these with disease activity and pain scores (WOMAC, VAS, and KOFUS), radiographic stage, inflammatory molecules and indices, and bone mineral density. DKK-1 levels were higher in the intensive pain group (VAS > 5) and positively correlated with the KOFUS throughout the study. This correlation was stronger in individuals with a BMI < 30. Serum DKK-1 levels were higher in patients with lower bone mineral density. No significant modifications in SOST, RANKL, or OPG levels were found in any of the above settings. In our patient cohort with mild-to-moderate knee osteoarthritis (OA), sclerostin, osteoprotegerin (OPG), and receptor activator of nuclear factor kappa-B ligand (RANKL) were not related to pain or disease activity. In contrast, DKK-1 was an indicator of pain and low-grade flare-ups. Furthermore, DKK-1 was associated with the KOFUS and impaired bone turnover in non-obese subgroups. Confirming these relationships in larger groups of patients would contribute to more efficient use of DKK-1 in disease stratification algorithms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School of Medicine and Pharmacy, I.O.S.U.D., George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
- Department M3, Rheumatology, BFK and Medical Rehabilitation, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
- Procardia Medical Center, Mihai Eminescu Street 3, 540043 Târgu Mureș, Romania.
- Department M3, Orthopedics-Traumatology 2, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 38 Gheorghe Marinescu Street, 540139 Târgu Mureș, Romania.
- Department M1, Pathology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 38 Gheorghe Marinescu Street, 540139 Târgu Mureș, Romania.
- Department F1, Biochemistry and Environmental Chemistry, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureș, 38 Gheorghe Marinescu Street, 540139 Târgu Mureș, Romania.
ORCID-Profile: Timea-Csilla Nagy-Finna, Árpád Sólyom, János Székely, Hunor Lukács, Előd Ernő Nagy
Zitieren
APA
Nagy-Finna, T. C., Sólyom, Á., Székely, J., Kikeli, P. I., Szövérfi, E. L., Lukács, H., Faragó, A. L., Horváth, E., Popoviciu, H., & Nagy, E. E. (2026). Serum Dkk-1 Is Associated with Pain Intensity, Flare-Ups, and Bone Mineral Density in Non-Obese Patients with Knee Osteoarthritis: A Single-Center, Cross-Sectional Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052216
Vancouver
Nagy-Finna TC, Sólyom Á, Székely J, Kikeli PI, Szövérfi EL, Lukács H, et al. Serum Dkk-1 Is Associated with Pain Intensity, Flare-Ups, and Bone Mineral Density in Non-Obese Patients with Knee Osteoarthritis: A Single-Center, Cross-Sectional Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052216
BibTeX
@article{NagyFinna2026,
author = {Nagy-Finna, Timea-Csilla and Sólyom, Árpád and Székely, János and Kikeli, Pál-István and Szövérfi, Erika-Lídia and Lukács, Hunor and Faragó, Anna-Lilla and Horváth, Emőke and Popoviciu, Horațiu and Nagy, Előd Ernő},
title = {Serum Dkk-1 Is Associated with Pain Intensity, Flare-Ups, and Bone Mineral Density in Non-Obese Patients with Knee Osteoarthritis: A Single-Center, Cross-Sectional Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052216}
}
EUVIMED